Morton R E, Greene D J
Department of Cell Biology, Lerner Research Institute, NC10, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195, USA.
Biochim Biophys Acta. 2000 Jul 19;1486(2-3):275-84. doi: 10.1016/s1388-1981(00)00064-0.
Lipid transfer inhibitor protein (LTIP) regulates cholesteryl ester transfer protein (CETP) activity by selectively impeding lipid transfer events involving low density lipoproteins (LDLs). We previously demonstrated that LTIP activity is suppressed in a dose-dependent manner by sodium oleate and that its activity can be blocked by physiological levels of free fatty acids [R.E. Morton, D. J. Greene, Arterioscler. Thromb. Vasc. Biol. 17 (1997)]. These data further suggested that palmitate has greater LTIP suppressive activity than oleate. In this report we define the ability of the major non-esterified fatty acids (NEFAs) in plasma to modulate LTIP activity. The greater suppression of LTIP activity by palmitate compared to oleate noted above was also seen in lipid transfer assays with various lipoprotein substrates and in the presence of albumin, showing that the relative effects of these two NEFAs are independent of assay conditions. To assess the effect of other NEFAs on LTIP activity, pure NEFAs were added to assays containing (3)H-cholesteryl ester labeled LDLs, unlabeled high density lipoproteins (HDLs) and CETP+/-LTIP. Whereas myristate, palmitate, stearate, oleate and linoleate stimulated CETP activity to varying extents, all NEFAs suppressed LTIP activity. Among these NEFAs, LTIP suppressive activity was greatest for the long-chain saturated and monounsaturated NEFAs. In contrast, linoleate and myristate were poor inhibitors of LTIP activity. The effects of increasing amounts of a given NEFA on LTIP activity correlated well with the increase in LDL negative charge induced by that NEFA, yet this relationship was unique for each NEFA, especially stearate. Notably, as measured by fluorescence anisotropy, the suppression of LTIP was highly and negatively correlated with the decreased order in the molecular packing of lipoprotein surface phospholipids caused by all NEFAs. Long-chain, saturated and monounsaturated NEFAs appear to be most effective in this regard partly because of their preferential association with LDLs where LTIP inhibition likely takes place. We hypothesize that NEFAs suppress LTIP activity by perturbing the surface properties of LDLs and counteracting the heightened molecular packing normally caused by LTIP. Diets rich in long-chain saturated and monounsaturated fatty acids may lead to a greater suppression of LTIP activity in vivo, which would allow LDLs to participate more actively in CETP-mediated lipid transfer reactions.
脂质转运抑制剂蛋白(LTIP)通过选择性地阻碍涉及低密度脂蛋白(LDL)的脂质转运事件来调节胆固醇酯转运蛋白(CETP)的活性。我们之前证明,油酸钠以剂量依赖的方式抑制LTIP的活性,并且其活性可被生理水平的游离脂肪酸阻断[R.E.莫顿,D.J.格林,《动脉硬化、血栓形成和血管生物学》17(1997年)]。这些数据进一步表明,棕榈酸酯比油酸酯具有更强的LTIP抑制活性。在本报告中,我们确定了血浆中主要非酯化脂肪酸(NEFA)调节LTIP活性的能力。在使用各种脂蛋白底物且存在白蛋白的脂质转运试验中,也观察到棕榈酸酯比上述油酸酯对LTIP活性的抑制作用更强,这表明这两种NEFA的相对作用与试验条件无关。为了评估其他NEFA对LTIP活性的影响,将纯NEFA添加到含有(3)H - 胆固醇酯标记的LDL、未标记的高密度脂蛋白(HDL)以及CETP + / - LTIP的试验中。肉豆蔻酸酯、棕榈酸酯、硬脂酸酯、油酸酯和亚油酸酯在不同程度上刺激了CETP活性,而所有NEFA均抑制LTIP活性。在这些NEFA中,长链饱和和单不饱和NEFA对LTIP的抑制活性最强。相比之下,亚油酸酯和肉豆蔻酸酯对LTIP活性的抑制作用较弱。给定NEFA量的增加对LTIP活性的影响与该NEFA诱导的LDL负电荷增加密切相关,但这种关系因每种NEFA而异,尤其是硬脂酸酯。值得注意的是,通过荧光各向异性测量,LTIP的抑制与所有NEFA引起的脂蛋白表面磷脂分子堆积有序性降低高度负相关。长链饱和和单不饱和NEFA在这方面似乎最有效,部分原因是它们优先与LDL结合,而LTIP的抑制可能发生在此处。我们推测,NEFA通过扰乱LDL的表面性质并抵消通常由LTIP引起的分子堆积增强来抑制LTIP活性。富含长链饱和和单不饱和脂肪酸的饮食可能会在体内导致对LTIP活性的更大抑制,这将使LDL更积极地参与CETP介导的脂质转运反应。